We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$499M
AUM Growth
-$99.5M
Cap. Flow
-$132M
Cap. Flow %
-26.33%
Top 10 Hldgs %
40.92%
Holding
243
New
104
Increased
7
Reduced
5
Closed
82

Sector Composition

Rank Sector Weight
1 Financials 22.3%
2 Technology 16.74%
3 Healthcare 11.05%
4 Industrials 10.4%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRXB.WS
151
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$276K 0.06%
+28,199
New +$30.3K
CLIM.WS
152
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$250K 0.05%
+25,379
New +$32.7K
TCVA
153
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$248K 0.05%
+25,000
New +$254K
VOSOW
154
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$248K 0.05%
+25,000
New +$22.7K
SRNGW
155
DELISTED
Soaring Eagle Acquisition Corp. Warrant
SRNGW
$229K 0.05%
+22,998
New +$57.6K
TSIBW
156
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$197K 0.04%
+20,000
New +$20.2K
LCAAW
157
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$162K 0.03%
+16,666
New +$14.4K
AAC.WS
158
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$156K 0.03%
+15,999
New +$16.9K
FTAAW
159
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$132K 0.03%
+13,448
New +$14.2K
SDSTW
160
Stardust Power Inc Warrant
SDSTW
$4.93M
$130K 0.03%
+13,333
New +$12.7K
DMYQ.WS
161
DELISTED
dMY Technology Group, Inc. IV Redeemable warrants, each whole warrant exercisable for one share of C
DMYQ.WS
$120K 0.02%
+12,323
New +$16.3K
BIDU icon
162
Baidu
BIDU
$37.7B
-4,945
Closed -$1.08M
BOX icon
163
Box
BOX
$4.37B
-70,000
Closed -$1.61M
COHR icon
164
Coherent
COHR
$51.4B
-10,000
Closed -$684K
HIG icon
165
Hartford Financial Services
HIG
$38.9B
-20,000
Closed -$1.34M
ON icon
166
CALL
ON Semiconductor
ON
$31.8B
-50,000
Closed -$2.08M
ORGN
167
DELISTED
Origin Materials
ORGN
-1,667
Closed -$505K
OWLT icon
168
Owlet
OWLT
$149M
-22,936
Closed -$3.18M
JWSM.U
169
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
-161,000
Closed -$1.63M
PLMIU
170
DELISTED
Plum Acquisition Corp. I Units
PLMIU
-49,996
Closed -$497K
CVIIU
171
DELISTED
Churchill Capital Corp VII Units
CVIIU
-206,190
Closed -$2.06M
GPACU
172
DELISTED
Global Partner Acquisition Corp II Unit
GPACU
-80,000
Closed -$789K
RMGCU
173
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
-242,135
Closed -$2.41M
ARRWU
174
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
-280,000
Closed -$2.78M
LCAAU
175
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
-50,000
Closed -$498K

Similar funds

Athos Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Athos Capital held 243 positions worth $499M, down 17% from $599M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Athos Capital withdrew a net $132M in Q2 2021, closing 82 positions and reducing 5 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Athos Capital opened a new position in Xilinx Inc worth $26.7M.

  • Athos Capital's largest Q2 2021 buy was Xilinx Inc: 184,800 shares worth $26.7M.
  • Athos Capital added most to Kansas City Southern in Q2 2021, an estimated $14.9M increase.
  • Athos Capital's biggest Q2 2021 reduction was DouYu International Holdings, cutting an estimated $10.5M.
  • Athos Capital fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $110M.
  • Athos Capital's ten largest holdings make up 41% of its $499M portfolio in Q2 2021.
  • Athos Capital opened 104 new positions and closed 82 in Q2 2021.
  • Athos Capital's portfolio value fell 17% quarter-over-quarter to $499M.

Based on Athos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.